Obstetrics & gynecology
Women’s health & pregnancy clinical trials
Reproductive health, pregnancy, and conditions specific to women. We’re tracking 6,335 recruiting studies in this area right now.
By phase
- Not applicable4,398
- Phase 2610
- Phase 1411
- Phase 3321
- Phase 4271
- Phase 1/Phase 2254
- Phase 2/Phase 370
Top conditions
- Ovarian Cancer338
- Cervical Cancer232
- Endometrial Cancer206
- Bladder Cancer190
- Acute Kidney Injury137
- Endometriosis135
- Pregnancy132
- Chronic Kidney Diseases131
- Breast Cancer107
- Chronic Kidney Disease105
- Infertility94
- Renal Cell Carcinoma81
- Colorectal Cancer74
- Preeclampsia73
- Pregnancy Related72
- Prostate Cancer65
- Pregnancy Complications63
- Urinary Incontinence63
Leading sponsors
- Mayo Clinic58
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS48
- Assistance Publique - Hôpitaux de Paris47
- IRCCS Azienda Ospedaliero-Universitaria di Bologna47
- M.D. Anderson Cancer Center45
- National Cancer Institute (NCI)41
- University of Colorado, Denver39
- Chinese University of Hong Kong38
- University of Aarhus36
- AstraZeneca35
Where studies are running
- California345
- Alabama155
- Texas121
- Massachusetts119
- New York118
- Florida103
- Arizona100
- Colorado90
- Maryland89
- Illinois78
Recruiting studies6,335 total
- NCT07020169Recruiting
Using AI 3D kidney models to guide partial nephrectomy
This trial tests if a 3D kidney model made with artificial intelligence helps surgeons remove a kidney tumor (partial nephrectomy) more precisely. It may help preserve healthy kidney tissue while treating the cancer.
Nanjing, JiangsuAges 18–80 - NCT07020104Recruiting
Salt and water in chronic kidney disease
This study looks at how salt builds up in the skin of people with chronic kidney disease. It involves different groups testing either sodium intake, sodium excretion, or water intake to see how these affect blood pressure and kidney function.
Amsterdam-Zuidoost, North HollandAges 18 years+ - NCT07021157RecruitingPhase 1
First-in-human study of SK-08 in healthy volunteers
This trial tests a new drug called SK-08 in healthy volunteers to see if it's safe and how the body processes it. It helps doctors find the right dose for future studies of this potential medicine.
Hangzhou, ZhejiangAges 18–45 - NCT07022418RecruitingPhase 2
Formoterol for diabetic kidney disease
This trial tests if a drug called formoterol (usually used for asthma) can help protect the kidneys in people with type 2 diabetes and early-to-moderate kidney disease. It may offer a new way to slow kidney damage.
Charleston, South CarolinaAges 18–75 - NCT07022470RecruitingPhase 2
Comparing 3 vs. 4 brachytherapy sessions for cervical cancer
This trial compares two different schedules of brachytherapy (a type of internal radiation) for cervical cancer. It aims to see if a shorter course of 3 treatments works just as well as the standard 4 treatments, which could mean fewer visits and less discomfort.
Palo Alto, CaliforniaAges 18 years+ - NCT07022535RecruitingPhase 2
Personalized timing of surgery for advanced ovarian cancer
This trial checks if adjusting the timing of surgery (interval debulking surgery) after chemotherapy can improve outcomes for people with advanced ovarian cancer. It's for those who cannot have surgery right away and will receive chemotherapy first.
Hong KongAges 18 years+ - NCT07022847Recruiting
Using a finger sensor to predict low blood pressure during dialysis
This trial tests if a non-invasive finger sensor (PVI) can predict when blood pressure drops during dialysis. If successful, it could help prevent dangerous low blood pressure episodes.
Wuhu, AnhuiAges 18–80 - NCT07023003RecruitingPhase 4
Blood pressure medicine study for new mothers
This study compares two blood pressure medicines, nifedipine and enalapril, for women who have high blood pressure related to pregnancy or chronic hypertension after giving birth. It aims to find the best option to help new mothers manage their blood pressure.
Omaha, NebraskaAges 19 years+ - NCT07023484RecruitingPhase 2
Timing of ovarian cancer surgery after chemo
This study looks at whether the timing of surgery after chemotherapy can be personalized for advanced ovarian cancer. It uses a blood test (CA125) to help decide the best time for surgery, aiming to improve outcomes.
GuangzhouAges 18 years+ - NCT07023432RecruitingPhase 2
Belzutifan vs. watchful waiting for slow-growing kidney cancer
This trial compares two approaches for people with slow-growing, metastatic clear cell kidney cancer: taking a daily pill (belzutifan) or monitoring the cancer closely without treatment. The goal is to see if starting treatment early can help control the cancer longer than waiting.
Houston, TexasAges 18 years+ - NCT07024680Recruiting
Sunitinib or sorafenib for papillary kidney cancer
This study looks at how well sunitinib or sorafenib work as a first treatment for a type of kidney cancer called papillary renal cell carcinoma (PRCC) that cannot be removed with surgery or has spread. It aims to understand real-world results in Chinese patients.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07024784RecruitingPhase 2
Study of IMGN151 for gynecologic cancers
This study tests a new drug (IMGN151) given intravenously, alone or with other therapies, for people with certain gynecologic cancers, specifically high-grade serous ovarian, fallopian tube, or primary peritoneal cancer. The goal is to see how well it works and what side effects might occur.
Teaneck, New JerseyAges 18 years+ - NCT07025044Recruiting
Bladder microbiome study for women with overactive bladder getting Botox
This study looks at the bacteria in the bladders of women with overactive bladder who are getting Botox injections. It aims to understand how these bacteria might affect treatment results.
Washington D.C., District of ColumbiaAges 55 years+ - NCT07025213Recruiting
Exercise and diet study for endometrial cancer before surgery
This study tests whether combining exercise with a special diet can improve how your body processes energy (metabolism) before you have surgery to remove the cancer. It is for people with early-stage endometrial cancer who haven't yet started treatment.
México, TlalpanAges 18–65 - NCT07025629RecruitingPhase 3
Dapagliflozin after ICU discharge for heart and kidney health
This study tests if the drug dapagliflozin (a medicine that helps protect the heart and kidneys) can improve recovery in patients who needed a breathing machine or blood pressure support in the ICU. If you qualify, you would take the drug after leaving the ICU to see if it lowers the risk of heart or kidney problems.
ParisAges 18 years+ - NCT07025642Recruiting
Overactive Bladder Treatments for Women
This study compares different treatments for overactive bladder in women in Taiwan. It aims to find the best approach to help control symptoms like frequent or urgent urination.
New Taipei CityAges 30–100 - NCT07025954Recruiting
Delivery at 36 vs. 37 weeks for placenta previa with accreta
This trial compares delivering at 36 weeks versus 37 weeks for pregnant women with a condition called placenta previa with accreta, where the placenta covers the cervix and grows too deeply into the womb. The goal is to find the best time for delivery to improve safety for both mother and baby.
Guangzhou, GuangdongAges 18–45 - NCT07026539RecruitingPhase 4
Finerenone for heart and kidney health in type 2 diabetes
This trial tests whether adding finerenone to your current diabetes medications can better protect your heart and kidneys. It is for people with type 2 diabetes who already take an SGLT2 inhibitor and an ACE inhibitor or ARB.
Aarhus NAges 18 years+ - NCT07027046Recruiting
A new robotic tool for endometrial cancer surgery
This trial is testing a newer, single-port robotic system (da Vinci SP) for staging surgery in endometrial cancer. It aims to see if this system is safe and effective for removing the uterus, ovaries, and possibly lymph nodes, with less scarring.
Naples, NapoliAges 18 years+ - NCT07028996Recruiting
Testing a new urine collection device for men
This study tests a new device called PEASY for collecting urine in men who have trouble controlling their bladder. It aims to see how well it works, if it's safe, and if it's comfortable to use.
NîmesAges 18 years+ - NCT07029503RecruitingPhase 2
Heart failure and kidney function study
This trial tests a new treatment for people with heart failure and severely reduced kidney function. It aims to see if the treatment can help protect both the heart and kidneys.
StockholmAges 18 years+ - NCT07030166Recruiting
Predicting kidney injury risk after non-cardiac surgery
This trial uses machine learning to predict the risk of acute kidney injury (AKI) after non-cardiac surgery. If you are 18 or older and having this type of surgery, it may help understand your risk and guide care.
NanjingAges 18 years+ - NCT07030257RecruitingPhase 1/Phase 2
Study of CP-383 for advanced solid tumors
This study tests a new drug called CP-383 for people with advanced solid tumors that have not responded to other treatments. The goal is to see if it can shrink tumors or slow cancer growth, especially for certain cancers with genetic changes.
Denver, ColoradoAges 18 years+ - NCT07030803Recruiting
Oxybutynin vs. nerve stimulation for overactive bladder in children
This trial compares two treatments for kids with overactive bladder: oxybutynin medicine and a painless nerve stimulation device. It aims to find which works better for reducing frequent, urgent, or leaky urination and nighttime accidents.
AmiensAges 6–16
Common questions
- How many women’s health & pregnancy clinical trials are recruiting?
- Clin2 is tracking 6,335 recruiting obstetrics & gynecology studies from the U.S. registry right now, out of 10,288 we cover in this area in total.
- What does “Women’s health & pregnancy” cover here?
- Reproductive health, pregnancy, and conditions specific to women. We group each study into women’s health & pregnancy based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a women’s health & pregnancy trial near me?
- Use the search to filter women’s health & pregnancy studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.